表紙
市場調査レポート

幹細胞:新たな製薬技術

Emerging Pharmaceutical Technologies - Stem cells

発行 CBR Pharma Insights 商品コード 290384
出版日 ページ情報 英文 53 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
幹細胞:新たな製薬技術 Emerging Pharmaceutical Technologies - Stem cells
出版日: 2012年08月15日 ページ情報: 英文 53 Pages
概要

幹細胞技術は今後の医薬品産業で大きな役割を果たそうとしています。創薬や疾患研究、薬剤開発、治療などの幅広い分野で、幹細胞の活用は多大な市場機会をもたらすと考えられていますが、現時点ではまだ証明できていません。それでも、市場競争から脱落しないためにも、製薬会社はその活用の動きに注目せざるを得ないでしょう。

当レポートでは、昨今の肝細胞研究の成果と、医療・製薬業界(研究開発(R&D)および臨床分野)に対する影響について分析すると共に、代表的企業のプロファイルや事業事例(ケーススタディ)などの情報を盛り込んで、概略以下の構成でお届けします。

第1章 イントロダクション

  • イントロダクション
  • 研究開発(R&D)への応用
  • 治療への応用
  • その他の課題
    • 規制
    • 価格設定・医療費償還

第2章 研究開発(R&D)への応用

  • 幹細胞はいかにして研究開発プロセスに革命をもたらすのか
  • 創薬に対する影響
  • がん幹細胞
  • 主な企業と事業事例

第3章 治療への応用

  • 主な開発領域

第4章 注目すべき企業

  • 主な幹細胞開発企業のプロファイル
  • 関心を示す製薬企業の増加

付録

目次
Product Code: CBRSV035

Stem cell technology is set to play a significant role in the pharmaceutical industry of the future. The opportunities for using stem cells across drug discovery, disease research, drug development and treatments are wide-ranging, yet largely unproven at present.

Even if companies are not interested in joining the first wave of stem cell therapy developers, they need to be monitoring this sector in order to understand future competitive threats.

The impact on drug discovery & development will impact the whole industry through a range of changes, from greater understanding of diseases to improved screening of drug candidates.

With R&D pipelines across the industry still under pressure, collaboration between academia, stem cell specialist companies, pharmaceutical companies and government& regulators is needed to ensure the smooth and rapid advancement of these technologies.

The report, "Emerging Pharmaceutical Technologies - Stem cells" has been written to support corporate strategy, new product development, business development, and R&D teams through its analysis of the trends being seen and the innovations taking place in this fast moving area. This report will support the corporate strategies and key decisions being made in this area through its analysis, insights, case studies, and company profiles included.

Scope

  • Stem Cell R&D applications
  • Stem Cell therapeutic applications
  • Profiles of leading stem cell developers

Key Reasons to Purchase

  • Benefit from CBR Pharma Insights' case study analysis of the key players, pharma companies, and key trials taking place to help support your corporate decision making
  • Gain a complete understanding of the Stem Cell landscape through our analysis of the developments that are taking place today and the companies who are going to impact the industry in the future
  • Learn about and gain insights on the key therapeutic applications that exit for stem cells in addition to the ways they can support drug discovery and the reinvigoration of your R&D pipeline
  • Balance the benefits associated with moving into the Stem Cell area with the challenges that exist to their ultimate success through our analysis of the issues associated with their use and the various applications where they can be utilized

Table of Contents

Chapter 1: Introduction

  • Introduction
  • R&D applications
  • Therapeutic applications
  • Other issues
    • Regulation
    • Pricing and reimbursement

Chapter 2: R&D Applications

  • How Stem Cells could revolutionize the R&D process
  • Drug discovery implications
  • Cancer stem cells
  • Key companies and case studies

Chapter 3: Therapeutic Applications

  • Key development areas

Chapter 4: Company Focus

  • Profiles of leading stem cell developers
  • Pharma company interest in the area increases

Appendix

Back to Top